DNAH17-AS1 promotes pancreatic carcinoma by increasing PPME1 expression via inhibition of miR-432-5p

doi:10.3748/wjg.v26.i15.1745

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 26, Issue 15

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6343)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-5) series, Tables (1-1) series.

Item

Count

PDF

392

WORD

133

HTML

3767

Figures (1-5)

285

Tables (1-1)

213

Sum=4790

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

580

Download

973

Sum=1553

Apr 21, 2020 (publication date) through Jul 26, 2024

Times Cited of This Article

Times Cited (19)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Gastroenterol. Apr 21, 2020; 26(15): 1745-1757
Published online Apr 21, 2020. doi: 10.3748/wjg.v26.i15.1745

Full Size Figure Download Figure

Figure 1 The expression of DNAH17-AS1 is upregulated in pancreatic carcinoma patients. A: Volcano plot of the TCGA_lncRNA profile. The top ten highly expressed lncRNAs are marked in green; B: The expression pattern of DNAH17-AS1 in pancreatic carcinoma (PC) patients and normal patients from The Cancer Genome Atlas dataset; C: DNAH17-AS1 expression in PC tissues collected by our hospital; D: DNAH17-AS1 expression in Hs766T, SW1990, and HPDE6-C7 cells; E: Dysregulation of DNAH17-AS1 is related to overall survival in PC patients; F: Dysregulation of DNAH17-AS1 is related to disease-free survival in PC patients. ^bP < 0.01. DFS: Disease-free survival; OS: Overall survival.

Citation: Xu T, Lei T, Li SQ, Mai EH, Ding FH, Niu B. DNAH17-AS1 promotes pancreatic carcinoma by increasing PPME1 expression via inhibition of miR-432-5p. World J Gastroenterol 2020; 26(15): 1745-1757
URL: https://www.wjgnet.com/1007-9327/full/v26/i15/1745.htm
DOI: https://dx.doi.org/10.3748/wjg.v26.i15.1745